Welcome to our dedicated page for Cognyte Software Ltd. SEC filings (Ticker: CGNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Cognyte Software Ltd.'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Cognyte Software Ltd.'s regulatory disclosures and financial reporting.
Cognyte Software Ltd. (CGNT) reported strong Q2 FYE27 results with accelerating software and recurring revenue growth and higher profitability. Q2 revenue was $109.2 million, up 12% year over year, driven by total software revenue of $100.8 million, which grew 20.9% and exceeded 92% of total revenue.
Recurring revenue rose 18.4% to $56.2 million, while Q2 non-GAAP operating income increased 52.5% to $12.2 million and adjusted EBITDA grew 35.7% to $14.9 million. Diluted non-GAAP EPS nearly doubled to $0.15, and diluted GAAP EPS tripled to $0.06. Operating cash flow turned positive at $1.1 million versus a use of cash a year ago.
For the first half of FYE27, revenue grew 11.2% to $214.7 million, adjusted EBITDA rose 33.7% to $28.5 million, and GAAP net income attributable to Cognyte was $1.1 million. The company ended Q2 with $102.2 million in cash and no debt, and has repurchased $40.2 million of shares since November 2024. Cognyte reiterated its FYE27 outlook, targeting revenue of $448 million, adjusted EBITDA of about $68 million, and non-GAAP diluted EPS of $0.47.
Cognyte Software Ltd. (CGNT) reports the results of its annual general meeting of shareholders for the fiscal year ending January 31, 2027, held on September 3, 2026 in Herzliya, Israel. Shareholders representing 46,705,281 ordinary shares, or 63.24% of the 73,845,238 outstanding shares as of August 3, 2026, were present in person or by proxy, establishing a quorum under the Articles of Association.
Shareholders approved both proposals recommended by the board. Dafna Sharir, Avi Cohen and Matthew O’Neill were re-elected as Class II directors to serve until the annual meeting to be held in the fiscal year ending January 31, 2030. Shareholders also approved the appointment of Kesselman & Kesselman, a member firm of PricewaterhouseCoopers International Limited, as independent auditors for the fiscal year ending January 31, 2027, and authorized the board, with possible delegation to its audit committee, to set their fees.
Cognyte Software Ltd. (CGNT) announced it will hold a conference call on September 9, 2026 at 8:30 a.m. ET to review its second quarter FYE27 financial results for the quarter ending July 31, 2026. An earnings press release will be released before the call.
The call will be webcast with presentation slides via Cognyte’s Investor Relations website, and participants who wish to join the question-and-answer session must register online in advance to receive dial-in details and a unique PIN.
Cognyte Software Ltd. reports that Chief Revenue Officer Adam Richard Philpott beneficially owns 89,485 Ordinary Shares, all represented by restricted share units granted on July 20, 2026. These RSUs vest in six semi-annual installments from January 20, 2027 through July 20, 2029, with 14,914 shares vesting on each of the first five dates and 14,915 shares on the final date.
Cognyte Software Ltd. will hold its Annual General Meeting on September 3, 2026, in Herzliya, Israel, for shareholders of record on August 3, 2026. Shareholders will vote on re-electing Dafna Sharir, Avi Cohen and Matthew O’Neill as Class II directors through the AGM for the fiscal year ending January 31, 2030, and on reappointing Kesselman & Kesselman (PwC) as independent auditors for the fiscal year ending January 31, 2027, with fees to be set by the Board (or Audit Committee). The Board recommends voting FOR all proposals.
For the fiscal year ended January 31, 2026, Cognyte reported revenue of $400.0 million, up 14.1% year over year, and non-GAAP gross profit of $292.0 million with a 73.0% non-GAAP gross margin. Adjusted EBITDA rose to $48.2 million, a 65.7% increase, and GAAP operating income was $13.3 million versus a $5.1 million loss in FYE25. The company ended FYE26 with $116.9 million in cash, no debt, and generated $29.7 million of free cash flow while executing a share repurchase program. In Q1 FYE27, non-GAAP revenue was $105.5 million, up 10.4% year over year.
Cognyte Software reported Q1 FYE27 revenue of $105.5 million, up 10.4% year over year, driven by strong demand for its investigative analytics software. GAAP operating income doubled to $4.4 million, while non-GAAP operating income rose to $10.7 million and adjusted EBITDA reached $13.6 million, up 31.5%.
The company still posted a GAAP net loss attributable to Cognyte of $3.0 million and used $4.7 million of net cash in operating activities, partly tied to subscription adoption, foreign exchange and inventory buildup. Cognyte ended the quarter with $109.2 million in cash and no debt, repurchased about one million shares for $8.2 million, and maintained its Fiscal 2027 outlook for $448 million in revenue, $68 million in adjusted EBITDA and non-GAAP diluted EPS of $0.47.
Cognyte Software Ltd. has scheduled a conference call for June 3, 2026, at 8:30am ET to review its first quarter FYE27 financial results for the quarter ending April 30, 2026. An earnings press release will be issued before the call.
The call will be webcast in real time with presentation slides via the Investor Relations section of Cognyte’s website, and participants can register online to receive dial‑in details for the live question-and-answer session.
CGNT reported a Form 144 filing showing a sale of securities by an insider. The filing lists 69,557 Ordinary Shares sold on 04/06/2026 for $640,491.70, brokered by Oppenheimer & Co. Inc. The excerpt also lists 60,656 Restricted Stock Units dated 03/26/2024.
CGNT filed a Form 144 disclosing an intended sale of 29,994 ordinary shares. The filing references Restricted Stock Units dated 05/11/2023 and lists prior sales of 39,563 shares on 04/06/2026 for $354,037. The broker shown is Oppenheimer & Co. Inc.
CGNT reported a Form 144 notice proposing the sale of ordinary shares issued under restricted stock unit awards. The filing lists multiple RSU grant dates and share quantities, including 12,000 shares (04/23/2021) and 13,863 shares (02/01/2021). Broker information shows Oppenheimer & Co. Inc. and the entry lists 04/06/2026 and NASDAQ.